Therefore, the mechanisms by which PDE5 inhibitors ameliorate fibrosis in SSc seem to be diverse, and whether there are other mechanisms of action of PDE5 inhibitors require further research. The gene discussed is PDE5A; the disease is systemic sclerosis.